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Purpose: To correlate in vivo confocal microscopy morphological features (IVCM-
MF) and Acanthamoeba cyst density (ACD) with final best corrected visual acuity 
(BCVA) in Acanthamoeba keratitis (AK).  
 
Design: Retrospective cohort study. 
 
Methods: Patient demographics, treatment outcome, and corresponding IVCM-MF 
performed at the acute stage of infection were analysed. Inclusion criteria were 
microbiological positive AK cases seen at Moorfields Eye Hospital between February 
2013 and October 2017. Statistical significance was assessed by multinomial 
regression and multiple linear regression analysis. Main outcome measures were 
final BCVA.   
 
Results: A total of 157 eyes (157 patients) had AK. Absence of single file of 
round/ovoid objects was associated with a BCVA of 6/36 to 6/9 (OR 8.13; 95% CI, 
1.55-42.56, P = 0.013) and ≥ 6/6 (OR 10.50; 95% CI, 2.12-51.92, P = 0.004) when 
compared to NPL to 6/60. Absence of rod/spindle objects was associated with a 
BCVA of ≥ 6/6 (OR 4.55; 95% CI, 1.01-20.45, P = 0.048). Deep stromal/ring infiltrate 
was associated with single file round/ovoid objects (OR 7.78; 95% CI, 2.69-22.35, P 
< 0.001), rod/spindle objects (OR 7.05; 95% CI, 2.11-23.59, P = 0.002), and binary 
round/ovoid objects (OR 3.45; 95% CI, 1.17-10.14, P = 0.024). There was a positive 
association between ACD with treatment duration (β = 0.14, P = 0.049), number of 
IVCM-MF (β = 0.34, P = 0.021) and clusters of round/ovoid objects (β = 0.29, P = 
0.002).    
 
Conclusions: Specific IVCM-MF correlate with ACD and clinical staging of disease, 






































































Acanthamoeba keratitis (AK) is a rare but potentially sight threatening infection. The 
organism Acanthamoeba is an opportunistic protozoan and it exists in two forms, an 
active trophozoite and a dormant cyst. The organism was first described as an ocular 
pathogen in 19741 but with the use of soft contact lenses, the incidence of AK has 
increased dramatically over the last two decades, especially in developed countries.2 
The initial presenting signs of AK can be similar to other forms of keratitis and it is 
often mistakenly diagnosed as herpes simplex keratitis (HSK).3 This delay in 
diagnosis and the potential injudicious use of topical steroids in treating presumed 
herpetic related inflammation, prior to anti-amoebic treatment, often results in poor 
visual outcome and severe inflammatory complications.3-5  
 
Current diagnostic methods of AK include culture, polymerase chain reaction (PCR), 
or in vivo confocal microscopy (IVCM). Culture yields poor sensitivity with a positive 
result ranging from 0 to 68%, whereas the sensitivity is greater with PCR but false-
negative results do occur.6 Various studies have shown the diagnostic accuracy of 
infectious keratitis with IVCM ranges from 56% to 100%,7-12 with characteristic 
morphological structures unique to Acanthamoeba also being identified using this 
technique.6,13,14 Such features of AK have also been demonstrated to be related to 
clinical prognosis and outcome. Specifically, a deep location of cysts and the 
presence of clusters or chains of cysts have been found to be significantly 
associated with a poorer visual outcome, this leading to making the assumption that 
the location of cysts and the pattern of cyst distribution are important prognostic 
indicators in AK.15  
 
The aim of this study was to correlate IVCM morphological features (IVCM-MF) and 
Acanthamoeba cyst density (ACD) with clinical staging and visual outcome in eyes 
cultured or polymerase chain reaction (PCR) positive for AK. In addition, we 






This was a retrospective, cohort study. Ethical approval was obtained from 
Moorfields Eye Hospital, London, United Kingdom, Research Ethics Committee 
(ROAD 15/042), and it adhered to the tenets of the Declaration of Helsinki. Patients 
were identified using an electronic medical database consisting of patients with AK 
who were treated at Moorfields Eye Hospital between February 2013 to October 
2017. Inclusion criteria consisted of all cultured or PCR positive cases for 
Acanthamoeba, clinical presentation consistent with AK, IVCM performed at the 
acute stage of the keratitis with round/cystic type lesions compatible with AK, and 
patients who have reached treatment completion. Treatment completion was defined 
as quiescence of disease for a period of 3 months or more on stopping anti-amoebic 
therapy. For patients with bilateral disease, the first affected eye was used for the 
analysis. Cases cultured positive for both Acanthamoeba and bacteria was classified 
as AK as bacteria, in general, are too small to be detected by IVCM.16 Cases that did 




































































Corneal scrapings for corneal culture were inoculated on a range of media as 
described previously.7 Culturing for Acanthamoeba from a cornea scrape was plated 
in non-nutrient agar which had been overlaid with Escherichia coli. All microbiological 
investigations were undertaken independently in an external laboratory (The Doctors 
Laboratory, London, UK).  
 
Clinical examination, treatment and data collection 
All patients underwent a clinical examination including Snellan visual acuity and slit 
lamp examination. AK corneal staging was classified into the following categories by 
a corneal specialist on diagnosis: 1 - epitheliitis, 2 - epitheliitis with perineural 
infiltrates, 3 - anterior stromal disease, 4 - deep stromal disease, and 5 - ring 
infiltrate.6,17 Scleritis associated with AK was classified to the most severe group (5 – 
ring infiltrate). All patients commenced on hourly anti-amoebic treatment for 5 days 
following diagnosis and the drugs then tapered according to clinical response. 
Treatment included either mono-therapy with a biguanide (polyhexamethylene 
biguanide or chlorhexidine gluconate) or dual therapy with a biguanide in 
combination with a diamidine (propamidine isethionate or hexamidine).    
 
The following patient demographics were recorded: age, symptom duration prior to 
diagnosis, previous treatment prior to the diagnosis of AK, prior topical steroid use, 
previous diagnosis of HSK, duration of anti-amoebic therapy, surgical intervention, 
and final best corrected visual acuity (BCVA).   
 
IVCM 
IVCM was performed using a standard operating procedure with the Heidelberg 
Retina Tomograph/Rostock Cornea Module (HRT II/RCM, Heidelberg Engineering, 
Dossenheim, Germany) confocal microscope by trained clinicians on the day of 
presentation.7 A sterile Tomocap (Heidelberg Engineering) was mounted over the 
objective of the microscope and 0.2% polyacrylic acid (Viscotears, Novartis, 
Camberley, UK) was used as a coupling agent between the cap and the lens 
objective. Topical anaesthetic (0.5% proxymetacaine hydrochloride, Bausch & Lomb, 
Kingston-upon-Thames, UK) and 1% Carmellose sodium (Celluvisc, Allergan, 
Marlow, UK) was instilled into both eyes prior to the examination. The instrument 
was brought into contact of the eye and the central region of the corneal ulcer or 
infiltrate was scanned first followed by the top, left, bottom and right margin of the 
affected area. Multiple volumes (a series of 40 images over 80µm depth) scans of 
the cornea from the superficial epithelium all the way down to the endothelium were 
recorded. Each en face image consists of 384 x 384 pixels covering an area of 400 
µm x 400 µm, providing a transverse resolution of approximately 1-2 µm.  
 
AK image selection and classification 
All available confocal images and sequences were reviewed by one experienced 
observer (SH) who was masked to the clinical outcome of the patients. In total, this 
equated to approximately 1200 images for each patient. Firstly, images were 
reviewed anteroposteriorly from the epithelium to endothelium and if round/ovoid, 
hyper-reflective objects (as defined below) were identified on one or more images 




































































Secondly, images were classified into the various IVCM-MF as follow: round/ovoid 
hyper-reflective objects, measuring 10-25 µm, without double wall; round/ovoid 
hyper-reflective objects, measuring 10-25 µm, with double wall; target sign - 
round/ovoid hyper-reflective central object, measuring 10-25 µm, with surrounding 
halo; signet ring - round hyper-reflective outer ring, measuring 10-25 µm, with a 
grey/dark center; cluster of round/ovoid hyper-reflective objects; hyper-reflective 
polygonal/stellate-type objects; binary round/ovoid hyper-reflective objects; 
trophozoite-like hyper-reflective objects, measuring 25-40 µm, with spindle shape 
projection from its surface suggestive of acanthopodia; single file or linear chains of 
round/ovoid hyper-reflective objects; coffee bean shape hyper-reflective objects; 
large hyper-reflective objects >30µm in size; and rod/spindle-shape hyper-reflective 
objects.6,18-20 Figure 1 shows the images of the various IVCM-MF classifications. 
Host inflammatory cellular features including the type of inflammatory cellular 
response; non- dendritiform cells (NDCs), dendritiform cells (DCs) or mixed,21-23 and 
whether the subbasal nerve plexus (SBNP) and keratocytes were visible or not, were 
also recorded. We defined DCs as bright specular structures with processes 
measuring up to 55µm in size and NDCs as irregular hyper-reflective structures 
measuring 10 to 40 µm in diameter without any dendritic form processes.21-23     
 
ACD estimation  
ACD estimation was performed by two experienced observers in assessing keratitis 
with IVCM: observer 1 (RC) has 7 years and observer 2 (SH) has 16 years of 
experience, respectively. Cyst counting was performed independently in a masked 
fashion by each observer and only images taken centrally from the cornea 
ulcer/infiltrate were used for ACD estimation. The depth of cysts infiltration was 
recorded into one of the following anatomical locations: epithelium only, epithelium 
and anterior stroma up to 250 µm, or present in the whole cornea. For each eye, up 
to 10 representative images from each anatomical location where cysts were 
present, were selected by one observer (SH). Only images where 1) the cystic 
morphology features were clearly visible, 2) focus and contrast were optimal, and 3) 
the entire image displayed the same corneal layer en face, without distortion, were 
selected for analysis.20 
 
Due to the difficulties in differentiating host inflammatory cells and keratocytes from 
trophozoites7 and other non-cystic morphologies, the following features were 
excluded from ACD estimation: polygonal/stellate-type objects (Fig 1F), trophozoite-
like objects (Fig 1H), coffee bean shape objects (Fig 1J), and large hyper-reflective 
objects > 30µm in size (Fig 1K). In addition, rod/spindle objects (Fig 1L), which do 
not resemble Acanthamoeba cysts, were not used for cyst density estimation. 
Therefore, only the cystic morphological features (Figure 1A – E, G and I) were used 
for ACD estimation. From the selected images, each observer subjectively chose 3 
images with the highest cyst count for ACD estimation.19 The cysts were marked 
manually over each 400 µm x 400 µm image, and the density determined using the 
proprietary built-in Cell Counting Software (cells/mm2) on the HRT II/RCM. If the 
cysts were present in more than one anatomical location then 3 images were chosen 
from each location (averaging 9 images per eye) and the ACD obtained by taking an 
average from all the images. The final mean ACD for each eye was obtained by 
averaging the counts between both observers.19 To assess intra- and interobserver 



































































occasions by each observer, separated by one month apart, with the images being 
re-randomised between assessments.   
 
Statistical analysis 
Data analysis was performed with SPSS software (IBM SPSS Statistics V24, USA). 
Descriptive statistics were used to summarise patient demographic data. Bland-
Altman plots were used to assess intra- and inter-observer agreement for ACD 
estimates.24 BCVA was used as the main outcome variable and it was stratified into 
3 categories: no perception of light (NPL) to 6/60 (used as the reference variable for 
comparison), 6/36 to 6/9, and better than or equal to (≥) 6/6. The rationale for the 
visual acuity stratification was to evaluate the level of vision that would entitle a 
patient to be potentially registered for sight impairment in the UK, the minimum visual 
acuity requirement for driving a vehicle, and the attainment of a normal level of 
BCVA, expected in age-matched healthy individuals, on resolution of the disease. In 
addition, the classification was chosen to minimise unequal sample comparison that 
could result in artefactual findings. Multinomial regression analysis was used to 
estimate the odds ratio (OR) with 95% confidence intervals (CI) to assess factors 
associated with the worst visual outcome category of NPL to 6/60. Univariate 
analysis was performed first followed by multivariable analysis. A separate binary 
logistic regression analysis assessing morphological features with disease severity 
on clinical presentation as the outcome variable, categorised by epithelial/anterior 
stroma disease ≤ 250 µm or deep stroma disease/ring infiltrate > 250 µm (as defined 
by the pachymetry measurements on IVCM) was performed. The association 
between various factors with ACD was analysed by univariate linear regression 
analysis followed by multiple linear regression analysis controlling for confounding 





A total of 171 eyes (171 patients) diagnosed with AK confirmed by culture or PCR 
positive for Acanthamoeba were identified over the study period. Of these, 14 eyes 
were excluded from the analysis: 4 due to equivocal diagnosis with IVCM because of 
poor image quality and 10 were excluded due to missing final outcome data or were 
lost to follow-up on completion of anti-amoebic treatment. Therefore, 157 eyes (157 
patients) were included for analysis. All of the patients in this study were contact lens 
wearers.  
 
Clinical characteristics and disease outcome 
Patient demographics and clinical characteristics are shown in Table 1. Of the 2 
eyes that needed an evisceration, one had a painful non-healing persistent epithelial 
defect (PED) over 6 months, and the second had recurrent corneal perforation and 
underwent 3 cornea transplants prior to evisceration. In total, 3 eyes were NPL, 
including the 2 eviscerated, and the third patient had a conjunctival autograft for PED 
and developed end stage secondary glaucoma. For the remaining 24 eyes in the 
category of NPL to 6/60, 13 (8.4%) did not receive any surgical intervention, 10 
(6.5%) had one or more corneal transplant, and 2 (1.3%) had an amniotic membrane 
graft. For the categories of 6/36 to 6/9, and ≥ 6/6, 7 (4.5%) had one or more corneal 



































































developed corneal perforation, 3 (1.9%) had a BCVA of NPL to 6/60, and 3 (1.9%) 
had a BCVA between 6/36 and 6/9. 
 
Comparison of clinical characteristics and final BCVA with univariate analysis is 
shown in Table 2. Multivariable analysis revealed the duration of anti-amoebic 
treatment to show a statistically significant association with a BCVA of 6/36 to 6/9 
(OR 0.83; 95% CI, 0.73 to 0.93, P = 0.002) and ≥ 6/6 (OR 0.77; 95% CI, 0.67 to 
0.88, P < 0.001) when compared to the BCVA category of NPL to 6/60. Furthermore, 
symptom duration < 3 weeks (OR 4.63; 95% CI, 1.03 to 21.41, P = 0.05), a prior 
diagnosis of HSK (OR 0.11; 95% CI, 0.02 to 0.86, P = 0.035), and absence of 
surgical intervention (OR 9.08; 95% CI, 1.23 to 67.19, P = 0.03) were associated 
with a BCVA of ≥ 6/6 when compared to NPL to 6/60.  
 
IVCM host cellular response   
The SBNP was visible in 20 (12.7%) eyes where the disease was confined to the 
epithelium and anterior stroma. The SBNP was not visible in any of the 37 (23.6%) 
eyes where there was a ring infiltrate or deep stromal involvement. Similarly, 
keratocytes were seen more often in disease confined to the epithelium and anterior 
stroma compared to deep stromal disease and/or ring infiltrate: 114 (82.1%) versus 
25 (17.9%), respectively. The distribution of inflammatory cell type detected include 
NDCs only in 51 eyes (32.5%), mixed DCs and NDCs in 99 eyes (63.1%), DCs only 
in 3 eyes (1.9%), and none detected in 4 eyes (2.5%). The 4 eyes where no obvious 
inflammatory cells were detected all had advanced disease with ring infiltrate and 
multiple cystic morphological features were visible throughout the central corneal 
stroma. 
    
IVCM-MF and disease outcome 
Comparison of the various IVCM-MF seen in AK and final BCVA on univariate 
analysis is shown in Table 3. In multivariable analysis, the absence of single file of 
round/ovoid hyper-reflective objects remained statistically significant in the 
association of a BCVA of 6/36 to 6/9 (OR 8.13; 95% CI, 1.55 to 42.56, P = 0.013) 
and ≥ 6/6 (OR 10.50; 95% CI, 2.12 to 51.92, P = 0.004) when compared to patients 
in the NPL to 6/60 category. Furthermore, the absence of rod/spindle-shaped hyper-
reflective objects (OR 4.55; 95% CI, 1.01 to 20.45, P = 0.048) was associated with a 
BCVA of ≥ 6/6 when compared to NPL to 6/60. Using disease severity on clinical 
presentation as the outcome variable, multivariable analysis showed the presence of 
deep stroma/ring infiltrate to be significantly associated with single file of round/ovoid 
hyper-reflective objects (OR 7.78; 95% CI, 2.69 to 22.35, P < 0.001), rod/spindle-
shape hyper-reflective objects (OR 7.05; 95% CI, 2.11 to 23.59, P = 0.002), and 




Bland-Altman plots show good intra- and inter-observer agreement with no obvious 
fixed or proportional bias detected for both observers, Figure 2. Multiple linear 
regression revealed a significant positive association between increase in ACD with 
duration of anti-amoebic treatment (β = 0.14, P = 0.049), total number of IVCM-MF 
(β = 0.34, P = 0.021) and clusters of round/ovoid hyper-reflective objects (β = 0.29, P 




































































The presence of single file or linear chains of round/ovoid hyper-reflective objects on 
diagnosis was independently and strongly associated with the poorest visual 
outcome of NPL to 6/60 in patients with AK. This morphological feature has 
previously been found to be present only in patients who were PCR-positive for 
Acanthamoeba, though it was not found to be significantly associated with AK. 
However, the authors did comment a larger series would be needed to determine the 
specificity of this feature in diagnosing AK.6 Comparatively, our cohort is much larger 
and we have demonstrated that this feature is a strong predictor for a visual outcome 
in the range of NPL to 6/60.  In addition, the presence of rod/spindle shape hyper-
reflective objects was significantly associated with a visual acuity of worse than 6/9. 
This morphological feature has been reported in all forms of keratitis including 
Acanthamoeba, bacterial and fungal keratitis.6,25 De Craene et al6 classified rod-
hyper-reflective objects separately from spindle-shape hyper-reflective objects and 
found the rod-shape phenotypes were seen only in PCR-positive cases whereas the 
spindle-shape phenotype were observed equally between PCR-positive and PCR-
negative cases. From our observation, it is difficult to distinguish these two 
phenotypes, hence the rationale for classifying all rod/shape features in the same 
category. Morphologically, rod/spindle-shape objects do not resemble 
Acanthamoeba cysts or trophozoites and it is plausible that they represent the 
spindle-shape fibroblasts and/or myofibroblasts seen during inflammation rather than 
the organism itself. The replacement of keratocytes by fibroblasts and myofibroblasts 
causes corneal haze and scar formation, resulting in visual loss.26  
 
Round/ovoid hyper-reflective objects without double wall were identified in all eyes in 
the study, and therefore they were not a good prognostic indicator. This feature has 
been described in numerous studies to be associated with AK,6,10,11,15,27,28 but also 
seen in 51.8% of PCR-negative patients in a previous case control study.6 Similarly, 
Fust et al29 found round/oval hyper-reflective objects were not specific for AK and 
were present in 40% of FK and 55% of BK, respectively. Although round/oval hyper-
reflective objects are seen in AK, the high rate of presence in non-AK challenges the 
assumption that these objects are specific for AK only.29  We found 3 further IVCM-
MF that were significantly associated with the poorest visual outcome on univariate 
analysis. Clusters of round/ovoid hyper-reflective objects were strongly associated 
with the BCVA category of NPL to 6/60. These clusters are highly specific for a 
diagnosis of AK but low in sensitivity.6 Binary hyper-reflective objects and target 
signs were also significantly associated with the poorest visual outcome. Similarly, 
target signs are pathognomonic of AK with high specificity but low sensitivity.6,29 
Furthermore, this sign has also been found to be present in over 80% of eyes with a 
clinical suspicion of AK.30 Trophozoite-like hyper-reflective objects have been 
reported to be associated with AK29,30 with high specificity6 but we did not find this to 
be a good prognostic indicator. Round/ovoid hyper-reflective objects with double 
wall, large hyper-reflective objects >30µm in size, coffee bean shape hyper-reflective 
objects, and hyper-reflective polygonal/stellate-type objects were also observed but 
were not significantly associated with visual outcome due to their relatively low 
frequency of presence. These signs have also been reported previously by De 




































































Using disease severity on clinical presentation as the outcome variable, single file 
round/ovoid, rod/spindle-shape, and binary round/ovoid hyper-reflective objects were 
significantly associated with the presence of deep stroma/ring infiltrate disease. The 
association of single file and rod/spindle shape objects with both disease severity 
and the poorest visual outcome category suggest these morphological signs are 
important prognostic indicators in patients with AK.    
 
We found good intra- and inter-observer agreement on cyst density estimation with 
no obvious systematic bias detected. The presence of cystic lesions in the stroma, a 
higher ACD and a greater number of different IVCM-MF were associated with the 
worst visual outcome category on univariate analysis. NPL to 60 eyes had nearly 
twice the cyst density compared to eyes with 6/36 to 6/9 and ≥ 6/6. This is in 
agreement with Huang et al who found a higher cyst density and deeper cyst 
invasion was associated with more severe disease.19 The mean ACD on 
presentation found in previous studies ranges between 99 to 214 cells/mm2,19,20 
which is higher than the mean ACD in our study even in the most severe disease 
group (84 cells/mm2). One possible reason for the difference is both cysts and 
trophozoite-like lesions were counted in the previous studies whereas only the cystic 
morphologies were counted in our study. Macrophages and other inflammatory cells 
are frequently confused with trophozoites, polygonal/stellate-type, and large hyper-
reflective objects, hence the reason for only using the various cystic morphologies 
for ACD estimation in our study.7 There is a paucity of data on the usefulness of 
ACD estimation with anti-amoebic treatment, the difficulty of ascertaining the viability 
of the cysts with treatment and how long before dead cysts are removed by the host 
immune system, make this difficult to assess, though it has been reported that cyst 
density reduces by 5.3% with each month of treatment.20 Furthermore, it has been 
found that after topical therapy, cysts demonstrating a hollow configuration existed 
for up to 6 months.31 These configurations could contribute to the variation in cystic 
morphology encountered in this study. However, we did not assess how cyst 
morphology and density changed with time or with medical therapy so further studies 
are needed to evaluate this.  
  
Host keratocyte cellular response was found to be dependent on disease severity 
with the presence of keratocytes more commonly observed in disease confined to 
the epithelium/anterior stroma. Chidambaram et al found eyes with AK were less 
likely to have normal keratocyte-like morphology compared to other causes of 
microbial keratitis. This is likely to be related to the cytopathic effects on keratocytes 
via induction of apoptosis from direct acanthamoebae adhesion.32,33 Furthermore, 
prolonged use of anti-amoebic therapy such as polyhexamethylene biguanide and 
chlorhexdine can potentially cause keratocyte cell death which is dose and time 
dependent.34 
 
The SBNP was only seen in 12.7% of eyes and was absent in all cases of deep 
stromal/ring infiltrate eyes. Although quantitative analysis of the nerves was not 
performed, others have shown a significant drop out of nerves during the acute 
phase of the infection35,36 A strong correlation between a reduction in cornea nerves 
and an increase in DC density with microbial keratitis has also been demonstrated.35 
We found 63% of eyes had both NDCs and DCs but we have not quantitatively 
analysed the inflammatory cell density in this study. Previous studies have reported 



































































highest DCs in the basal epithelium whereas Chidambaram reported DCs to be the 
highest in bacterial keratitis when compared to other forms of keratitis.25,35 These 
authors cited the difference may be related to prior steroid treatment in a large 
proportion of their patients. DCs and NDCs are merely morphological descriptions of 
the type of presumed immune cells seen on IVCM and it is not possible, with current 
technology, to determine the exact phenotype of these cells or to be able to 
competently differentiate pathogenic organism from inflammatory cells.25 Moreover, it 
is not known if the inverse relationship between corneal nerves and inflammatory 
cells seen during the acute phase of the infection with IVCM is related to direct 
cytopathic effect from the pathogen itself on the nerves or to the severe cornea host 
inflammatory response.35,36 We have not assessed recovery of the SBNP during the 
course or on resolution of the disease but it has been shown that nerve regeneration 
does occur during the first 6 months after resolution of the infection but it is still 
reduced when compared to controls.36        
 
Nearly 50% of patients achieved a final BCVA of ≥ 6/6 on resolution of the disease, 
which is comparable to previous studies.17 Patients with ring infiltrate received anti-
amoebic treatment on average twice as long compared to patients with epithelial 
disease and this is reflected by the significant association of a poorer visual outcome 
with the longer duration of therapy. We found a shorter duration of patient symptoms 
prior to the diagnosis of AK to be associated with a better visual outcome on 
univariate analysis but on multivariable analysis, only the ≥ 6/6 BCVA category was 
significant. Our definition of symptom duration of greater or less than 3 week was the 
same as Tu et al who found patients presenting ≥ 3 week were more likely a to have 
a final visual acuity of less than 20/25 (6/7.5) but they did not find this to be 
statistically significant on univariate analysis, citing the subjective nature of symptom 
onset recall by patients to be potentially unreliable.17 Although our acuity definition of 
≥ 6/6 is different to the study by Tu al, our findings of an association between a 
poorer visual outcome with symptom duration prior to diagnosis is in agreement with 
previous studies.37  We also found a prior diagnosis of HSK and the need for surgical 
intervention were more likely to be associated with the BCVA of NPL to 6/60 when 
compared to ≥ 6/6 but not when compared to the category of 6/36 to 6/9 on 
multivariable analysis. Prior diagnosis of HSK was not found to be a significant 
predictor by Tu et al; our much lower visual acuity reference standard for comparison 
is likely to be the reason for the difference found. Surgical intervention was 
associated with the poorest visual outcome category, aside from the 3 eyes who 
were NPL, 11/24 eyes needed some form of surgical intervention in this category.  
 
The main limitation of our study is the retrospective design and only the first scan on 
presentation was used for prognostication purpose. A recent study has shown that 
monitoring ACD during treatment can be useful to assess therapeutic response, but 
the relationship between the changes in ACD with treatment for different stages of 
severity for AK was not assessed.20 We demonstrated that disease severity on 
presentation is associated with a higher ACD and greater number of IVCM-MF so it 
is likely that the changes in cyst density with treatment would be different for more 
severe disease. Further longitudinal studies are needed to evaluate the relationship 
between ACD change with time and disease severity. Nevertheless, we have shown 
good repeatability and reproducibility with ACD estimation when performed by 
experienced observers, and this is important when ACD is potentially used as a 



































































classifications on previous publications but this process is subjective, and the 
difficulty in differentiating Acanthamoeba cysts or trophozoites from inflammatory 
cells, damaged epithelial cells and keratocytes, shows the limitations with current 
IVCM technology.6,7 The strengths of our study include the larger sample size, only 
culture or PCR positive for Acanthamoeba was used as the reference standard for 
case selection, and trained experienced observers were used for both morphological 
classification and ACD determination.  
 
In conclusion, we found specific IVCM-MF correlate with ACD and clinical staging of 
disease on presentation and therefore, can be used as potential prognostic 
indicators for visual outcome in patients with AK. Further studies are required to 
evaluate how these morphological features evolve over the course of therapeutic 
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Figure 1.  
In vivo classification of the various morphological features seen in Acanthamoeba 
keratitis.  
A. Round/ovoid hyper-reflective objects, measuring 10-25 µm, without double wall, 
B. Round/ovoid hyper-reflective objects, measuring 10-25 µm, with double wall, C. 
Target sign - round/ovoid hyper-reflective central object, measuring 10-25 µm, with 
surrounding halo, D. Signet ring - round hyper-reflective outer ring, measuring 10-25 
µm, with a grey/dark center, E. Cluster of round/ovoid hyper-reflective objects, F. 
Hyper-reflective polygonal/stellate-type objects, G. Binary round/ovoid hyper-
reflective objects, H. Trophozoite-like hyper-reflective objects, measuring 25-40 µm, 
I. Single file or linear chains of round/ovoid hyper-reflective objects, J. Coffee bean 
shape hyper-reflective objects, K. Large hyper-reflective objects >30µm in size, L. 
Rod/spindle-shape hyper-reflective objects. 
 
Figure 2.  
Bland-Altman plots for intra-observer and inter-observer difference against the 
average Acanthamoeba cyst density. The dash line represents the mean difference 
and the dotted lines indicates the 95% limits of agreement. The dark marker opacity 
reflects density of overlapping points. (Top) Intra-observer difference for observer 1, 
the mean difference is 0.13 ± 0.76. (Middle) Intra-observer difference for observer 2, 
the mean difference is 0.03 ± 1.31. (Bottom) inter-observer difference, the mean 
difference is 0.11 ± 1.54. 
 
TABLE 1. Patient demographics and clinical characteristics (n = 157) 
Age (yrs), mean (SD , range) 41.5 (15.7, 20-81) 
Sex – female, n (%) 87 (55.4) 
Symptom duration prior to diagnosis (weeks), mean (SD , range) 4.7 (6.8, 0.3-56) 
Previous diagnosis, n (%)  
      Bacteria keratitis 47 (29.9) 
      Uncertain  40 (25.5) 
      HSV  28 (17.8) 
      Possible AK  35 (22.3) 
      Fungus 2 (1.3) 
      Adenovirus  2 (1.3) 
      Uveitis  1 (0.6) 
      Contact lens related abrasion  1 (0.6) 
      Conjunctivitis  1 (0.6) 
Topical treatment prior to diagnosis of AK, n (%)  
      Antibiotic 83 (52.9) 
      Steroid 37 (23.6) 
      Antiviral 28 (17.8) 
      Anti-amoebic 34 (21.7) 
Slit lamp appearance, n (%)  
      Epitheliitis 60 (38.2) 
      Epitheliitis with perineural infiltrate 34 (21.7) 
      Anterior stromal infiltrate 26 (16.6) 
      Deep stromal/ring infiltrate 37 (23.6) 
Culture positive for acanthamoeba, n (%) 72 (45.9) 
 PCR positive for acanthamoeba, n (%)      120 (76.4) 
Culture and PCR positive for acanthamoeba, n (%)      42 (26.8) 
Duration of anti-amoebic treatment (months), mean (SD , range)  
      Epithelial disease 6.9 (4.5,1-23) 
      Stromal disease  9.1 (5.4, 2-27) 
      Ring infiltrate  14.3 (6.9, 4-24) 
Final best corrected visual acuity, n (%)  
      NPL to 6/60 27 (17.2) 
      6/36 to 6/9  55 (35) 
      ≥ 6/6 75 (47.8) 
Corneal perforation, n (%) 6 (3.8) 
Surgical intervention, n (%)  
      None 132 (84.1) 
      Corneal transplant 21 (13.4) 
      Amniotic membrane graft for PED 3 (1.9) 
      Evisceration   2 (1.3) 
  
SD = standard deviation; AK = Acanthamoeba keratitis; PCR = polymerase chain 




TABLE 2. Comparison of clinical characteristics, IVCM findings, and final BCVA (n = 157) 
 
BCVA 
NPL to 6/60a 
(n = 27) 
BCVA 
6/36 to 6/9 




(n = 75) 
Univariate analysis 
Clinical 




Value n % OR 95% CI 
P 
Value 
Symptom duration (weeks) 
< 3 4 5.6 24 33.8 4.45 1.36– 14.60 0.01 43 60.6 7.73 
2.43– 
24.55 0.001 
≥ 3 23 26.7 31 36.0    32 37.2    
Previous steroid therapy 
No 18 15.0 38 31.7 1.12 0.42– 2.98 0.83 64 53.3 2.91 
1.00– 
8.10 0.041 
Yes 9 24.3 17 45.9    11 29.7    
Previous anti-amoebic therapy 
No 18 14.6 44 35.8 2.00 0.71– 5.65 0.19 61 49.6 2.18 
0.81– 
5.86 0.12 
Yes 9 26.5 11 32.4    14 41.2    
Previous diagnosis of HSK 
No 25 19.4 47 36.4 0.47 0.09– 2.38 0.36 57 44.2 0.25 
0.06– 
1.18 0.08 
Yes 2 7.1 8 28.6    18 64.3    
Clinical appearance 





Stroma/ring 19 30.2 23 36.5    21 33.3    
IVCM – morphological features location 
Epithelium 










and stroma 24 32.9 22 30.1    27 37.0    
IVCM – ACD (number/per mm²) 
 84.9 ±60.5b  
48.2 




±40.1b  0.99 
0.98– 
0.99 0.001 
IVCM – number of different morphological features 
 5.7 ± 1.6b  
3.8 ± 











Duration of anti-amoebic treatment (months) 
 15.6 ±6.0b  
8.6 

















Yes 14 58.3 8 33.3    2 8.3    
BCVA = best corrected visual acuity; NPL = no perception of light; OR = odds ratio; CI = confidence 
intervals; HSK = herpes simplex keratitis, IVCM = in vivo confocal microscopy; ACD = Acanthamoeba 
cyst density 
a NPL to 6/60 group was used as the reference for comparison  
b Values presented as mean and standard deviation  
Table 2
TABLE 3. Comparison of the various IVCM morphological features and final BCVA (n = 157) 
 
BCVA 
NPL to 6/60a 
(n = 27) 
BCVA 
6/36 to 6/9 





(n = 75) 
Univariate analysis 
Morphological 




Value n % OR 
95% 
CI P Value 
Round/ovoid hyper-reflective objects without double wall 
No 0  0  NA NA NA   NA NA NA 
Yes 27 17.2 55 35.0    75 47.8    
Round/ovoid hyper-reflective objects with double wall 
No 10 12.0 32 38.6 2.37 0.92–6.10 0.075 41 49.4 2.05 
0.83–
5.06 0.12 
Yes 17 23.0 23 31.1    34 45.9    
Target sign 
No 2 4.3 21 45.7 7.72 1.67–35.99 0.009 23 50 5.53 
1.21–
25.32 0.028 
Yes 25 22.5 34 30.6    52 46.8    
Signet sign 
No 23 18.5 42 33.9 0.56 0.16– 1.92 0.359 59 47.6 0.64 
0.19– 
2.12 0.467 
Yes 4 12.1 13 39.4    16 48.5    
Single file of round/ovoid hyper-reflective objects 
No 7 5.7 48 39.0 19.59 6.08–63.15 
< 
0.001 68 55.3 27.76 
8.69–
88.56 < 0.001 
Yes 20 58.8 7 20.6    7 20.6    
Cluster of round/ovoid hyper-reflective objects 
No 7 6.3 44 39.3 11.43 3.86–33.83 
< 
0.001 61 54.5 12.45 
4.41–
35.16 < 0.001 
Yes 20 44.4 11 24.4    14 31.1    
Trophozoite-like hyper-reflective objects 
No 21 20.2 35 33.7 0.50 0.17–1.44 0.2 48 46.2 0.51 
0.18–
1.41 0.19 
Yes 6 11.3 20 37.7    27 50.8    
Rod/spindle-shape hyper-reflective objects 
No 13 9.8 48 36.4 7.39 2.47–22.07 
< 
0.001 71 53.8 19.12 
5.43–
67.30 < 0.001 
Yes 14 56 7 28.0    4 16    
Binary round/ovoid hyper-reflective objects 
No 7 8.6 28 34.6 2.96 1.08–8.14 0.035 46 56.8 4.53 
1.70–
12.05 0.002 
Yes 20 26.3 27 35.5    29 38.2    
Large hyper-reflective objects > 30μm 
No 24 18.2 45 34.1 0.56 0.14–2.24 0.42 63 47.7 0.66 
0.17–
2.53 0.54 
Yes 3 12.0 10 40.0    12 48    
Coffee bean shape hyper-reflective objects 
No 27 17.5 54 35.1 NA NA NA 73 47.4 NA NA NA 
Yes 0 0.0 1 33.3    2 66.7    
Table 3
Polygonal/stellate objects < 30μm 
No 27 17.4 54 34.8 NA NA NA 74 47.7 NA NA NA 
Yes 0 0.0 1 50.0    1 50    
BCVA = best corrected visual acuity; NPL = no perception of light; IVCM = in vivo confocal microscopy; 
OR = odds ratio; CI = confidence intervals; NA = not applicable - odds ratio not calculated due to very 
low value or value only present in one of the two binary outcome  
a NPL to 6/60 group was used as the reference for comparison 
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